SYDNEY, June 15 (Reuters) - Australian liver cancer treatment maker Sirtex Medical Ltd expects its $1.4 billion buyout by a Chinese consortium to will win regulatory approval in Australia and the ...
Sirtex will support and assist OncoSec with pre-marketing activities for TAVO™ and its visceral lesion applicator (VLA) in exchange for low single-digit royalties on those products. Sirtex is a global ...
Interim CEO unanimously chosen to lead global operations in patient-first oncology innovation WOBURN, Mass., Oct. 16, 2019 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver ...
Add Yahoo as a preferred source to see more of our stories on Google. SYDNEY, July 3 (Reuters) - The former head of Australian liver-cancer treatment firm Sirtex Medical Ltd has pleaded guilty to ...
Sirtex Medical, an Australian biotech, received an unsolicited $1.41 billion counteroffer from Chinese fund manager CDH Investments. The counteroffer by CDH is a nonbinding, indicative and conditional ...
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer HCC is the ...
WOBURN, Mass., Oct. 27, 2023 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the commercial availability of the LAVA® Liquid ...
Agreement includes board position and exclusive negotiation period for further collaborative access to AuroLase® Therapy in other non-U.S. geographies WOBURN, Massachusetts, Sept. 8, 2020 /PRNewswire/ ...
Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories. "This milestone is about more than regulatory approval-it's about giving hope and options back ...
Varian Medical Systems Inc. agreed to buy Australia’s Sirtex Medical Ltd. for about A$1.6 billion ($1.3 billion) in a bid by the U.S. company to add radiation medicine to its portfolio for cancer ...
The former head of Australian liver-cancer treatment firm Sirtex Medical Ltd has pleaded guilty to insider trading, Australia's corporate regulator said on Wednesday. SYDNEY, July 3 (Reuters) - The ...
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results